Clinical collaborative research of CBHI and Hallym University
Clinical collaborative research of CBHI and Hallym University on the bone density increase
by SAC in postmenopausal women
Calcium and Bone Health Institute (CBHI, http://www.cbhi.info), a nonprofit clinical research institute in Canada joined hands with Hallym University in South Korea for a collaborative clinical “evaluative study of SAC (Sigma Anti-Bonding Calcium Carbonate) treatment effects in women with postmenopausal osteopenia.” Professor Lee Sang-soo, the director of the Skeletal Aging Research Institute in Hallym University School of Medicine and Professor Ryu Ok-hyun will lead this research.
Effects of Sigma Anti-bonding Molecule Calcium Carbonate on Bone Turnover and Calcium Balance in Ovariectomized Rats
Effects of Sigma Anti-bonding Molecule Calcium Carbonate on Bone Turnover and Calcium Balance in Ovariectomized Rats
Research result.
Evaluation of SAC-Calcium’s Bone Health Improvement Efficacy – Sungkyunkwan University
A Study on the Effectiveness of SAC-Calcium in Improving Bone Health
Joint research project aims to evaluate the effectiveness of Sigma Anti-bonding Calcium (SAC-Calcium) in promoting bone health, particularly in postmenopausal conditions. With support from CBHI, this study will be conducted by Sungkyunkwan University and focuses on scientific validation of SAC-Calcium’s biological benefits.
